Pfizer Begins Spinoff Of Animal Health Business
The move follows the $11.85 billion sale of its infant nutrition unit to Nestle SA in April as the world's biggest drugmaker looks to squeeze more growth from its core biopharmaceutical division. New York-based Pfizer had been exploring options, including spinoffs and sales, for both units since last summer.
It said it...
To view the full article, register now.